openPR Logo
Press release

Migraine Drugs Market by Type (Abortive Medicine and Preventive Medicine), Route of Administration (Oral, Injection, and Others), and Distribution Channel (Hospital-based Pharmacies, Retail Pharmacies and Online Pharmacies) - Global Opportunity Analysis a

01-24-2023 04:55 PM CET | Health & Medicine

Press release from: Analytics Market Research

Global Migraine Drugs Market

Global Migraine Drugs Market

Migraine Drugs Market Overview:
The market for migraine medications, which had a global market value of $1,713 million in 2017, is anticipated to increase to $2,190 million by 2025, with a CAGR of 3.1% from 2023 to 2032. Migraine is a medical ailment that causes excruciating headaches as well as other symptoms like nausea and sensitivity to smell. Each migraine episode differs in length and intensity, and they often affect one side of the brain. Drugs for migraine are used to treat headaches brought on by migraines.

The market for migraine medications is driven by an increase in migraine prevalence. Additionally, a rise in female population and a rise in patient awareness of migraine prevention and treatment are major drivers of market expansion. However, one issue impeding market expansion is the negative effects connected with migraine medication. On the other hand, it is anticipated that the important companies will have new prospects due to the growth opportunities in rising nations.

Based on type, route of administration, distribution channel, and area, the research divides the market for migraine medications. The market is divided into preventive medicine and abortive medicine based on kind. It is divided into oral, injectable, and other forms depending on the method of delivery. Hospital-based pharmacies, retail pharmacies, and online pharmacies are the three categories under which it is broken down. It is examined regionally across North America (the United States, Canada, and Mexico), Europe (the Netherlands, Belgium, France, Italy, Spain, and the rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and the rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Migraine is a neurological medical disease that causes severe, excruciating headaches. Numbness, nauseousness, vomiting, and difficulty speaking are possible symptoms. Additionally genetically linked, migraines can affect people of all ages. External factors including alcohol, hormone fluctuations, stress, and dietary allergies can all contribute to a pounding headache. Most migraines can be treated on one's own. Nevertheless, analgesics, non-steroidal anti-inflammatory drugs, antipsychotics, and other medications are required in extreme situations. The increasing acceptance of a sedentary lifestyle has made migraines more common in younger individuals. Future market development is expected to be favourably impacted by it.

Competitive Strategy
The leading players are now concentrating on implementing strategies like product innovations, mergers & acquisitions, new advancements, joint ventures, collaborations, and partnerships to strengthen their market position in the worldwide acute migraine medications market.

Market Growth & Trends
Recurrent occurrences of migraine, a main headache illness, are typically symptoms. Some of the most frequently prescribed pharmaceuticals for the treatment of migraine are ergot alkaloids, inflammatory agents, nonsteroidal anti-inflammatory drug combination analgesics, triptans, and acetaminophen. Due to the difficulty in forecasting individual responses to a certain dose or the high likelihood of medication nonresponse, treating acute migraines can be difficult. Abortive therapy is primarily employed as soon as the disease manifests symptoms to treat it. Despite regulations advocating non-opioid therapy, opioids are typically defined as acute migraines in the emergency department (ED). Adults with acute migraines receive prochlorperazine, intrathecal metoclopramide, and subcutaneous sumatriptan. According to the National Survey on Drug Use and Health (NSDUH), 86.5% of people aged 19 and older reported drinking alcohol at some point in their lives, with roughly 68.4% saying they had done so within the previous year. In the upcoming years, these figures are expected to increase fast, driving the market's growth.

Click Here To Get PDF Sample: https://analyticsmarketresearch.com/sample-request/migraine-drugs-market/41055/

Market Segmentations:
Global Migraine Drugs Market: Major Players
Merck
Teva
Pfizer
Pfizer
GlaxoSmithKline
Abbott
Endo International
Allergan
Johnson and Johnson
Impax

Global Migraine Drugs Market: By Types
Sumatriptan
Zolmitriptan
Rizatriptan

Global Migraine Drugs Market: By Applications
Hospitals
Clinics
Household Use

Global Migraine Drugs Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Migraine Drugs market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.

Know More: https://analyticsmarketresearch.com/reports/migraine-drugs-market/41055/

COVID-19 Analysis:
Migraine patients were negatively impacted by the COVID-19 epidemic. As one of the most debilitating chronic neurological conditions, migraine sufferers are especially susceptible to the catastrophic adverse effects of the pandemic. Due to a number of factors, including increased psychosocial stress, social isolation, disruption of sleep and eating patterns, and many COVID-19-specific problems, migraine patients may no longer respond to treatment as effectively as they once did. This is especially true when face-to-face appointments or procedural treatments are postponed. The use of contemporary technologies like phone calls and Internet apps has been made by headache units all over the world in an effort to adapt. Unfortunately, not all nations were able to offer the same standard of treatment, which has frequently led to a decline in patient management.

Click Here To Buy Market Report: https://analyticsmarketresearch.com/purchase/migraine-drugs-market/41055/?license=single

Key Questions Answered in This Report:
• How has the global migraine drugs market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global migraine drugs market?
• What are the key regional markets?
• What is the breakup of the market based on the treatment type?
• What is the breakup of the market based on the drug type?
• What is the breakup of the market based on the route of administration?
• What is the breakup of the market based on the distribution channel?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global migraine drugs market and who are the key players?
• What is the degree of competition in the industry?

Contact US:
Analytics Market Research
99 WALL STREET, #2124 NEW YORK, NY 10005
Phone: +1(650)-666-4592
Email: sales@analyticsmarketresearch.com
Website: * https://analyticsmarketresearch.com/contactus/
Let's connect on LinkedIn: https://www.linkedin.com/company/analytics-market-research/
Let's connect on Facebook: https://www.facebook.com/people/Analytics-Market-Research/100086022874594/
Let's connect on Twitter: https://twitter.com/AnalyticsMRR

About US:
Analytics Market Research is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. Analytics Market Research is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Migraine Drugs Market by Type (Abortive Medicine and Preventive Medicine), Route of Administration (Oral, Injection, and Others), and Distribution Channel (Hospital-based Pharmacies, Retail Pharmacies and Online Pharmacies) - Global Opportunity Analysis a here

News-ID: 2898225 • Views:

More Releases from Analytics Market Research

Global Texture Paint Market Rising Trends, Technology Research and Advancement Outlook 2023 to 2033
Global Texture Paint Market Rising Trends, Technology Research and Advancement O …
The Global Texture Paint Market size was valued at USD 12,400 million in 2022 and is projected to reach USD 16,700 million by 2033, growing at a CAGR of 4.5% during the forecast period. The texture paint market refers to the industry involved in the production, distribution, and sale of texture paints. Texture paints are specialized coatings used to add texture and visual interest to surfaces, such as walls, ceilings, furniture,
Guarding the Global Flow: Exploring the Growth Potential and Security Innovations in the Global Supply Chain Market (2023-2032)
Guarding the Global Flow: Exploring the Growth Potential and Security Innovation …
The global Supply Chain Security Market size was valued at USD 2.56 billion in 2022, and is projected to reach USD 3.57 billion by 2032 at a CAGR of 11.5% from 2023 to 2032. The supply chain security market refers to the set of solutions and services aimed at securing the flow of goods, services, and information across the global supply chain. The primary objective of supply chain security is to
Clouding the Future: Unveiling the Global Public Cloud Market's Transformation and Forecast by 2032
Clouding the Future: Unveiling the Global Public Cloud Market's Transformation a …
The global public cloud market was estimated at USD 211.5 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 14.6% from 2023 to 2032. Rapid progress of digital transformation in the industry, prevalence of internet and mobile devices, and increasing consumption of big data are the major drivers of market growth. Developing next-generation industrial solutions is leveraging the cloud and requires a platform that
Revolutionizing Education: Exploring the Global Learning Management System Market's Growth Trajectory, Key Players, and Predictions for the Decade Ahead (2023-2032)
Revolutionizing Education: Exploring the Global Learning Management System Marke …
The global Learning Management System Market size was valued at USD 27.56 billion in 2022, and is projected to reach USD 62.57 billion by 2032 at a CAGR of 18.5% from 2023 to 2032. A Learning Management System (LMS) is a software application designed to manage and deliver educational and training courses, resources, and assessments to learners. It is used by educational institutions, businesses, and organizations to create and deliver courses,

All 5 Releases


More Releases for Migraine

Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share? The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size? The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market? The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes. Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market. The objectives outlined in the report are multifaceted and aimed at offering a comprehensive
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases. The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs. Get Access to TOC /